Biallelic Loss-of-Function Variants in AIMP1 Cause a Rare Neurodegenerative Disease.
Document Type
Article
Publication Date
2-1-2019
Abstract
AIMP1/p43, is a noncatalytic component of the mammalian multi-tRNA synthetase complex that catalyzes the ligation of amino acids to their cognate tRNAs. AIMP1 is largely expressed in the central nervous system, where it is part of the regulatory machine of the neurofilament assembly, playing a crucial role in neuronal development and function. To date, nonsense mutations in AIMP1 have been associated with a primary neurodegenerative disorder consisting of cerebral atrophy, hypomyelination, microcephaly and epilepsy, whereas missense mutations have recently been linked to intellectual disability without neurodegeneration. Here, we report the first French-Canadian patient with a novel frameshift AIMP1 homozygous mutation (c.191_192delAA, p.Gln64Argfs*25), resulting in a severe neurodegenerative phenotype. We review and discuss the phenotypic spectrum associated with AIMP1 pathogenic variants.
Journal Title
Journal of child neurology
Volume
34
Issue
2
First Page
74
Last Page
80
MeSH Keywords
Atrophy; Brain; Child, Preschool; Cytokines; Demyelinating Diseases; Epilepsy; Female; Frameshift Mutation; Humans; Microcephaly; Neoplasm Proteins; Neurodegenerative Diseases; RNA-Binding Proteins
Keywords
intellectual disability; leukodystrophy; neurodevelopment; seizures; spasticity
Recommended Citation
Accogli A, Guerrero K, D'Agostino MD, et al. Biallelic Loss-of-Function Variants in AIMP1 Cause a Rare Neurodegenerative Disease. J Child Neurol. 2019;34(2):74-80. doi:10.1177/0883073818811223
COinS
Comments
Grant support